Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Garware Hi-Tech Films Limited (GRWRHITECH.NS)
INR6,991.00
-46.00 (-0.65%)
IN NSE Basic Materials Chemicals - Specialty
Address
Garware House 400057
Mumbai, RJ, IN
Mumbai, RJ, IN
CEO
Shashikant Garware
Website
garwarehitechfilms.com
IPO
2022-02-03
ISIN INE291A01017
Also trades on
Bombay Stock Exchange · GRWRHITECH.BO (INR)
National Stock Exchange of India · GRWRHITECH.NS (INR)
Description
Garware Hi-Tech Films Ltd. is a holding company, which engages in the manufacture of polyester films. It operates through the following geographical segments: Within India, China, and Rest of the World. Its products include polyester film/BOPET, BOPP, thermal lamination, and coated label. The company was founded by Bhalchandra Digamber Garware in 1933 and is headquartered in Mumbai, India.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR6,991.00
-46.00 (-0.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
116.9K
Beta
0.68
Float Shares
8.28M
Free Float %
35.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.70% | +2.46% | +41.68% | +34.47% | +38.96% | +81.21% | +30.36% | +744.94% | +563.95% | +563.95% | +563.95% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
6,991.00
DCF (Unlevered)
2,799.81
-60.0%
DCF (Levered)
2,065.36
-70.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
0% Bullish
| Rating | 2025-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
23.33
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+2.1% Q1'26: +15.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+2.1% Q1'26: +39.1% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.2% Q1'26: +12.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.4% ★ Q1'26: +20.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+15.6% ★ Q1'26: +19.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.04× ★ Q1'26: 0.03× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.55B
est: 8.68B (-1.5%)
|
8.14B
est: 8.33B (-2.3%)
|
9.25B
est: 8.33B (+11.0%)
|
9.04B
est: 9.39B (-3.7%)
|
9.71B
est: 8.88B (+9.3%)
|
12.75B
est: 9.68B (+31.7%)
|
16.52B
est: 16.15B (+2.3%)
|
20.77B
est: 21.21B (-2.1%)
|
21.43B
21.43B – 21.43B
+1.0% YoY
|
25.49B
25.49B – 25.49B
+18.9% YoY
|
| EBITDA |
566.27M
est: 1.81B (-68.8%)
|
767.33M
est: 1.74B (-55.9%)
|
1.49B
est: 1.74B (-14.3%)
|
1.70B
est: 1.96B (-13.1%)
|
2.29B
est: 1.85B (+23.6%)
|
2.73B
est: 2.02B (+34.9%)
|
3.17B
est: 3.37B (-5.8%)
|
4.90B
est: 4.67B (+4.8%)
|
4.72B
4.72B – 4.72B
+1.0% YoY
|
5.62B
5.62B – 5.62B
+18.9% YoY
|
| EBIT |
434.43M
est: 1.62B (-73.1%)
|
631.00M
est: 1.55B (-59.3%)
|
1.35B
est: 1.55B (-12.9%)
|
1.50B
est: 1.75B (-14.2%)
|
2.05B
est: 1.65B (+24.0%)
|
2.44B
est: 1.80B (+35.6%)
|
2.78B
est: 3.01B (-7.4%)
|
4.48B
est: 4.27B (+5.0%)
|
4.32B
4.32B – 4.32B
+1.0% YoY
|
5.13B
5.13B – 5.13B
+18.9% YoY
|
| Net Income |
224.43M
est: 202.35M (+10.9%)
|
331.24M
est: 276.93M (+19.6%)
|
816.50M
est: 276.93M (+194.8%)
|
860.19M
est: 724.84M (+18.7%)
|
1.26B
est: 800.81M (+57.3%)
|
1.67B
est: 877.01M (+90.6%)
|
2.03B
est: 2.09B (-2.9%)
|
3.31B
est: 3.48B (-4.9%)
|
3.17B
3.17B – 3.17B
-9.1% YoY
|
4.23B
4.23B – 4.23B
+33.7% YoY
|
| SGA |
773.74M
est: 682.85M (+13.3%)
|
769.44M
est: 655.18M (+17.4%)
|
806.87M
est: 655.18M (+23.2%)
|
948.51M
est: 738.13M (+28.5%)
|
1.08B
est: 698.54M (+55.0%)
|
1.24B
est: 761.41M (+63.4%)
|
1.43B
est: 1.27B (+12.5%)
|
1.79B
est: 2.33B (-23.0%)
|
2.35B
2.35B – 2.35B
+1.0% YoY
|
2.80B
2.80B – 2.80B
+18.9% YoY
|
| EPS |
9.66
est: 8.71 (+10.9%)
|
14.26
est: 11.92 (+19.6%)
|
35.14
est: 11.92 (+194.8%)
|
37.03
est: 31.20 (+18.7%)
|
54.21
est: 34.47 (+57.3%)
|
71.96
est: 37.75 (+90.6%)
|
87.50
est: 90.10 (-2.9%)
|
142.57
est: 149.90 (-4.9%)
|
136.30
136.30 – 136.30
-9.1% YoY
|
182.20
182.20 – 182.20
+33.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.60B
OE per share TTM
68.94
Owner's Yield
1.22%
Maintenance CapEx ratio
149.47%
Maint CapEx / Avg PPE
97.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 9 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 68.5K | 0.48% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 154.6K | 0.26% |
| 3 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 12.3K | 0.22% |
| 4 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 36.9K | 0.22% |
| 5 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 19.9K | 0.22% |
| 6 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 8.7K | 0.22% |
| 7 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 1.0K | 0.22% |
| 8 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 332.02 | 0.31% |
| 9 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 158.10 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.95M
Shares Outstanding
23.23M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shashikant Bhalchandra Garware | Chairman & MD | 141M | — |
| Monika Rajiv Garware Modi | Vice Chairperson & Joint MD | 130M | female |
| Sarita Garware Ramsay | Joint MD & Director | 99M | female |
| Uday Vasantrao Joshi | Whole Time Director | 6M | male |
| Nikhil Sharma | Chief People Officer | — | male |
| Sunil Wadikar | President of Corporate Affairs & Finance | — | male |
| A. Venkatraman | Senior President of Corporate Affairs & Finance | — | male |
| Yogesh Chavan | President of Human Resource Management | — | male |
| Abhishek Agarwal | President Accounts & Chief Financial Officer | — | male |
| Awaneesh K. Srivastava | Vice President of Legal, Company Secretary & Compliance Officer | — | male |
| Deepak Joshi | Head Sales & Marketing | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GRWRHITECH.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
